CXCL17: The Black Sheep in the Chemokine Flock

Stepan Denisov

Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, Netherlands,

Edited by: Ji Ming Wang, National Cancer Institute at Frederick, United States

Reviewed by: Barbara Molon, University of Padua, Italy

*Correspondence: Stepan S. Denisov, ln.ytisrevinuthcirtsaam@vosined.s

This article was submitted to Cytokines and Soluble Mediators in Immunity, a section of the journal Frontiers in Immunology

Edited by: Ji Ming Wang, National Cancer Institute at Frederick, United States

Reviewed by: Barbara Molon, University of Padua, Italy

Received 2021 May 21; Accepted 2021 Jun 28.

Keywords: chemokines, CXCL17, DMC, VCC-1, CXCL8

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

References

1. Miller MC, Mayo KH. Chemokines From a Structural Perspective. Int J Mol Sci (2017) 18:1–16. 10.3390/ijms18102088 ] [
2. Hughes CE, Nibbs RJB. A Guide to Chemokines and Their Receptors. FEBS J (2018) 285:2944–71. 10.1111/febs.14466 ] [
3. Xiao S, Xie W, Zhou L. Mucosal Chemokine CXCL17: What Is Known and Not Known. Scand J Immunol (2021) 93:1–7. 10.1111/sji.12965 [] [[PubMed]
4. Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, et al. . The Secreted Protein Discovery Initiative (SPDI), A Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics Assessment. Genome Res (2003) 13:2265–70. 10.1101/gr.1293003 ] [
5. Pisabarro MT, Leung B, Kwong M, Corpuz R, Frantz GD, Chiang N, et al. . Cutting Edge: Novel Human Dendritic Cell- and Monocyte-Attracting Chemokine-Like Protein Identified by Fold Recognition Methods. J Immunol (2006) 176:2069–73. 10.4049/jimmunol.176.4.2069 [] [[PubMed]
6. Weinstein EJ, Head R, Griggs DW, Sun D, Evans RJ, Swearingen ML, et al. . VCC-1, A Novel Chemokine, Promotes Tumor Growth. Biochem Biophys Res Commun (2006) 350:74–81. 10.1016/j.bbrc.2006.08.194 [] [[PubMed]
7. Lee W-Y, Wang C-J, Lin T-Y, Hsiao C-L, Luo C-W. CXCL17, An Orphan Chemokine, Acts as a Novel Angiogenic and Anti-Inflammatory Factor. Am J Physiol Endocrinol Metab (2013) 304:E32–40. 10.1152/ajpendo.00083.2012 [] [[PubMed]
8. King RD, Sternberg MJE. Identification and Application of the Concepts Important for Accurate and Reliable Protein Secondary Structure Prediction. Protein Sci (1996) 5:2298–310. 10.1002/pro.5560051116 ] [
9. Wang X, Watson C, Sharp JS, Handel TM, Prestegard JH. Oligomeric Structure of the Chemokine CCL5/RANTES From NMR, MS, and SAXS Data. Structure (2011) 19:1138–48. 10.1016/j.str.2011.06.001 ] [
10. Nordsieck K, Baumann L, Hintze V, Pisabarro MT, Schnabelrauch M, Beck-Sickinger AG, et al. . The Effect of Interleukin-8 Truncations on its Interactions With Glycosaminoglycans. Biopolymers (2018) 109:e23103. 10.1002/bip.23103 [] [[PubMed]
11. von Hundelshausen P, Agten SM, Eckardt V, Blanchet X, Schmitt MM, Ippel H, et al. . Chemokine Interactome Mapping Enables Tailored Intervention in Acute and Chronic Inflammation. Sci Transl Med (2017) 9:eaah6650. 10.1126/scitranslmed.aah6650 [] [[PubMed]
12. Sun C, Shen H, Cai H, Zhao Z, Gan G, Feng S, et al. . Intestinal Guard: Human CXCL17 Modulates Protective Response Against Mycotoxins and CXCL17-Mimetic Peptides Development. Biochem Pharmacol (2021) 188:114586. 10.1016/j.bcp.2021.114586 [] [[PubMed]